200,000+ products from a single source!
sales@angenechem.com
38739-13-8 | 3-Bromo-L-tyrosine
CAS No: 38739-13-8 Catalog No: AG0033MV MDL No:MFCD09836116
Product Description
Catalog Number:
AG0033MV
Chemical Name:
3-Bromo-L-tyrosine
CAS Number:
38739-13-8
Molecular Formula:
C9H10BrNO3
Molecular Weight:
260.0846
MDL Number:
MFCD09836116
IUPAC Name:
(2S)-2-amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid
InChI:
InChI=1S/C9H10BrNO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1
InChI Key:
HGWOSUKIFQMEIF-ZETCQYMHSA-N
SMILES:
OC(=O)[C@H](Cc1ccc(c(c1)Br)O)N
Properties
Complexity:
212
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
258.984g/mol
Formal Charge:
0
Heavy Atom Count:
14
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
260.087g/mol
Monoisotopic Mass:
258.984g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
83.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.7
Literature
| Title | Journal |
|---|---|
| Association of brominated proteins and changes in protein expression in the rat kidney with subcarcinogenic to carcinogenic doses of bromate. | Toxicology and applied pharmacology 20131015 |
| Selenium-containing amino acids are targets for myeloperoxidase-derived hypothiocyanous acid: determination of absolute rate constants and implications for biological damage. | The Biochemical journal 20120101 |
| Oxidative stress in schizophrenia. | Current neuropharmacology 20110601 |
| Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. | Journal of clinical biochemistry and nutrition 20110101 |
| Brominated compounds from marine sponges of the genus Aplysina and a compilation of their 13C NMR spectral data. | Marine drugs 20110101 |
| Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis. | Free radical biology & medicine 20101115 |
| The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages. | The Biochemical journal 20100815 |
| Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation. | The Journal of biological chemistry 20100319 |
| Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20091001 |
| Quantification of Modified Tyrosines in Healthy and Diabetic Human Urine using Liquid Chromatography/Tandem Mass Spectrometry. | Journal of clinical biochemistry and nutrition 20090101 |
| Preparation and Characterization of a Polyclonal Antibody against Brominated Protein. | Journal of clinical biochemistry and nutrition 20090101 |
| Simultaneous detection and quantification of 3-nitrotyrosine and 3-bromotyrosine in human urine by stable isotope dilution liquid chromatography tandem mass spectrometry. | Toxicology letters 20080901 |
| Capillary electrophoresis for monitoring dityrosine and 3-bromotyrosine synthesis. | Journal of chromatography. A 20060127 |
| Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. | Archives of biochemistry and biophysics 20060115 |
| Characterization of oxidative pathways in chronic rhinosinusitis and sinonasal polyposis. | American journal of rhinology 20060101 |
| Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. | American journal of respiratory and critical care medicine 20050801 |
| Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. | The Journal of allergy and clinical immunology 20041201 |
| Nonenzymatic preparative-scale synthesis of dityrosine and 3-bromotyrosine. | Analytical biochemistry 20041101 |
| NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis. | Magnetic resonance in medicine 20041001 |
| Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge. | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20040601 |
| Kinetic analysis of the reactions of hypobromous acid with protein components: implications for cellular damage and use of 3-bromotyrosine as a marker of oxidative stress. | Biochemistry 20040427 |
| Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics. | Free radical biology & medicine 20020915 |
| Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. | Analytical biochemistry 20020115 |
| Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. | Journal of immunology (Baltimore, Md. : 1950) 20010501 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.